| Nov 7 |
ANI Pharmaceuticals Q3 2024 Earnings Preview
|
| Nov 4 |
ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in November
|
| Nov 2 |
ANI Pharmaceuticals Is Acting Like It Is Being Acquired
|
| Nov 1 |
Earnings Preview: ANI Pharmaceuticals (ANIP) Q3 Earnings Expected to Decline
|
| Oct 30 |
ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET
|
| Oct 25 |
ANI Pharmaceuticals launches estradiol gel after final FDA approval
|
| Oct 25 |
ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.06%
|
| Oct 24 |
ANI Pharmaceuticals to Present New Data Highlighting Membranous Nephropathy Research at American Society of Nephrology Kidney Week 2024
|
| Oct 23 |
ANI Pharmaceuticals price target raised to $62 from $60 at Truist
|
| Oct 17 |
Are Medical Stocks Lagging Alnylam Pharmaceuticals (ALNY) This Year?
|
